Evidence / Submission
Submission Health innovation Smarter investment Commercialisation International collaboration Philanthropy

Submission on the Complying Investment Framework for the Significant Investor Visa (SIV) and Premium Investor Visa (PIV) Programmes

Research Australia 22 December 2014 2014 · Submission

In brief

Research Australia suggests that wealthy migrants applying for investor visas should be able to count donations to medical research charities, and Private Ancillary Funds supporting medical research, towards their required investment. It argues this would bring in new philanthropy and help early-stage research reach the point where commercial investors are interested.

Abstract

This short submission responds to Austrade’s invitation for public submissions on the complying investment framework for the Significant Investor Visa (SIV) and Premium Investor Visa (PIV) programmes. Noting that Australian health and medical research (H&MR) has more capacity than funding and has previously attracted overseas philanthropists such as Atlantic Philanthropies and the Gates Foundation, Research Australia proposes that donations to H&MR organisations registered as charities, and Private Ancillary Funds established to support H&MR in Australia, be counted as complying investments. It maintains such donations could help fund the early-stage work needed to reach commercial proof of concept and build relationships with future investors. It generally supports including venture capital funds.

Published22 December 2014
Type Submission
Platform Health innovation, Smarter investment
Topic Commercialisation, International collaboration, Philanthropy
AuthorResearch Australia
Format3 pages · PDF